title: Acute lymphoblastic leukemia.
abstract: The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multi-disciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL.
authors: Joseph C
authors: JC
authors: Alvarnas
authors: Patrick A
authors: PA
authors: Brown
authors: Patricia
authors: P
authors: Aoun
authors: Karen Kuhn
authors: KK
authors: Ballen
authors: Naresh
authors: N
authors: Bellam
authors: William
authors: W
authors: Blum
authors: Michael W
authors: MW
authors: Boyer
authors: Hetty E
authors: HE
authors: Carraway
authors: Peter F
authors: PF
authors: Coccia
authors: Steven E
authors: SE
authors: Coutre
authors: Jennifer
authors: J
authors: Cultrera
authors: Lloyd E
authors: LE
authors: Damon
authors: Daniel J
authors: DJ
authors: DeAngelo
authors: Dan
authors: D
authors: Douer
authors: Haydar
authors: H
authors: Frangoul
authors: Olga
authors: O
authors: Frankfurt
authors: Salil
authors: S
authors: Goorha
authors: Michael M
authors: MM
authors: Millenson
authors: Susan
authors: S
authors: O'Brien
authors: Stephen H
authors: SH
authors: Petersdorf
authors: Arati V
authors: AV
authors: Rao
authors: Stephanie
authors: S
authors: Terezakis
authors: Geoffrey
authors: G
authors: Uy
authors: Meir
authors: M
authors: Wetzler
authors: Andrew D
authors: AD
authors: Zelenetz
authors: Maoko
authors: M
authors: Naganuma
authors: Kristina M
authors: KM
authors: Gregory
mesh_terms: D006801:Humans; D018365:Neoplasm, Residual; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*; D011379:Prognosis; D012307:Risk Factors